Safety of the Deferral of Coronary Revascularization on the Basis of Instantaneous Wave-Free Ratio and Fractional Flow Reserve Measurements in Stable Coronary Artery Disease and Acute Coronary Syndromes
The aim of this study was to investigate the clinical outcomes of patients deferred from coronary revascularization on the basis of instantaneous wave-free ratio (iFR) or fractional flow reserve (FFR) measurements in stable angina pectoris (SAP) and acute coronary syndromes (ACS). Assessment of coro...
Saved in:
| Published in | JACC. Cardiovascular interventions Vol. 11; no. 15; pp. 1437 - 1449 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
Elsevier Inc
13.08.2018
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The aim of this study was to investigate the clinical outcomes of patients deferred from coronary revascularization on the basis of instantaneous wave-free ratio (iFR) or fractional flow reserve (FFR) measurements in stable angina pectoris (SAP) and acute coronary syndromes (ACS).
Assessment of coronary stenosis severity with pressure guidewires is recommended to determine the need for myocardial revascularization.
The safety of deferral of coronary revascularization in the pooled per-protocol population (n = 4,486) of the DEFINE-FLAIR (Functional Lesion Assessment of Intermediate Stenosis to Guide Revascularisation) and iFR-SWEDEHEART (Instantaneous Wave-Free Ratio Versus Fractional Flow Reserve in Patients With Stable Angina Pectoris or Acute Coronary Syndrome) randomized clinical trials was investigated. Patients were stratified according to revascularization decision making on the basis of iFR or FFR and to clinical presentation (SAP or ACS). The primary endpoint was major adverse cardiac events (MACE), defined as the composite of all-cause death, nonfatal myocardial infarction, or unplanned revascularization at 1 year.
Coronary revascularization was deferred in 2,130 patients. Deferral was performed in 1,117 patients (50%) in the iFR group and 1,013 patients (45%) in the FFR group (p < 0.01). At 1 year, the MACE rate in the deferred population was similar between the iFR and FFR groups (4.12% vs. 4.05%; fully adjusted hazard ratio: 1.13; 95% confidence interval: 0.72 to 1.79; p = 0.60). A clinical presentation with ACS was associated with a higher MACE rate compared with SAP in deferred patients (5.91% vs. 3.64% in ACS and SAP, respectively; fully adjusted hazard ratio: 0.61 in favor of SAP; 95% confidence interval: 0.38 to 0.99; p = 0.04).
Overall, deferral of revascularization is equally safe with both iFR and FFR, with a low MACE rate of about 4%. Lesions were more frequently deferred when iFR was used to assess physiological significance. In deferred patients presenting with ACS, the event rate was significantly increased compared with SAP at 1 year.
[Display omitted] |
|---|---|
| AbstractList | OBJECTIVES The aim of this study was to investigate the clinical outcomes of patients deferred from coronary revascularization on the basis of instantaneous wave-free ratio (iFR) or fractional flow reserve (FFR) measurements in stable angina pectoris (SAP) and acute coronary syndromes (ACS). BACKGROUND Assessment of coronary stenosis severity with pressure guidewires is recommended to determine the need for myocardial revascularization. METHODS The safety of deferral of coronary revascularization in the pooled per-protocol population (n = 4,486) of the DEFINE-FLAIR (Functional Lesion Assessment of Intermediate Stenosis to Guide Revascularisation) and iFR-SWEDEHEART (Instantaneous Wave-Free Ratio Versus Fractional Flow Reserve in Patients With Stable Angina Pectoris or Acute Coronary Syndrome) randomized clinical trials was investigated. Patients were stratified according to revascularization decision making on the basis of iFR or FFR and to clinical presentation (SAP or ACS). The primary endpoint was major adverse cardiac events (MACE), defined as the composite of all-cause death, nonfatal myocardial infarction, or unplanned revascularization at 1 year. RESULTS Coronary revascularization was deferred in 2,130 patients. Deferral was performed in 1,117 patients (50%) in the iFR group and 1,013 patients (45%) in the FFR group (p < 0.01). At 1 year, the MACE rate in the deferred population was similar between the iFR and FFR groups (4.12% vs. 4.05%; fully adjusted hazard ratio: 1.13; 95% confidence interval: 0.72 to 1.79; p = 0.60). A clinical presentation with ACS was associated with a higher MACE rate compared with SAP in deferred patients (5.91% vs. 3.64% in ACS and SAP, respectively; fully adjusted hazard ratio: 0.61 in favor of SAP; 95% confidence interval: 0.38 to 0.99; p = 0.04). CONCLUSIONS Overall, deferral of revascularization is equally safe with both iFR and FFR, with a low MACE rate of about 4%. Lesions were more frequently deferred when iFR was used to assess physiological significance. In deferred patients presenting with ACS, the event rate was significantly increased compared with SAP at 1 year. (C) 2018 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation. OBJECTIVES: The aim of this study was to investigate the clinical outcomes of patients deferred from coronary revascularization on the basis of instantaneous wave-free ratio (iFR) or fractional flow reserve (FFR) measurements in stable angina pectoris (SAP) and acute coronary syndromes (ACS). BACKGROUND: Assessment of coronary stenosis severity with pressure guidewires is recommended to determine the need for myocardial revascularization. METHODS: The safety of deferral of coronary revascularization in the pooled per-protocol population (n = 4,486) of the DEFINE-FLAIR (Functional Lesion Assessment of Intermediate Stenosis to Guide Revascularisation) and iFR-SWEDEHEART (Instantaneous Wave-Free Ratio Versus Fractional Flow Reserve in Patients With Stable Angina Pectoris or Acute Coronary Syndrome) randomized clinical trials was investigated. Patients were stratified according to revascularization decision making on the basis of iFR or FFR and to clinical presentation (SAP or ACS). The primary endpoint was major adverse cardiac events (MACE), defined as the composite of all-cause death, nonfatal myocardial infarction, or unplanned revascularization at 1 year. RESULTS: Coronary revascularization was deferred in 2,130 patients. Deferral was performed in 1,117 patients (50%) in the iFR group and 1,013 patients (45%) in the FFR group (p < 0.01). At 1 year, the MACE rate in the deferred population was similar between the iFR and FFR groups (4.12% vs. 4.05%; fully adjusted hazard ratio: 1.13; 95% confidence interval: 0.72 to 1.79; p = 0.60). A clinical presentation with ACS was associated with a higher MACE rate compared with SAP in deferred patients (5.91% vs. 3.64% in ACS and SAP, respectively; fully adjusted hazard ratio: 0.61 in favor of SAP; 95% confidence interval: 0.38 to 0.99; p = 0.04). CONCLUSIONS: Overall, deferral of revascularization is equally safe with both iFR and FFR, with a low MACE rate of about 4%. Lesions were more frequently deferred when iFR was used to assess physiological significance. In deferred patients presenting with ACS, the event rate was significantly increased compared with SAP at 1 year. OBJECTIVES The aim of this study was to investigate the clinical outcomes of patients deferred from coronary revascularization on the basis of instantaneous wave-free ratio (iFR) or fractional flow reserve (FFR) measurements in stable angina pectoris (SAP) and acute coronary syndromes (ACS). BACKGROUND Assessment of coronary stenosis severity with pressure guidewires is recommended to determine the need for myocardial revascularization. METHODS The safety of deferral of coronary revascularization in the pooled per-protocol population (n = 4,486) of the DEFINE-FLAIR (Functional Lesion Assessment of Intermediate Stenosis to Guide Revascularisation) and iFR-SWEDEHEART (Instantaneous Wave-Free Ratio Versus Fractional Flow Reserve in Patients With Stable Angina Pectoris or Acute Coronary Syndrome) randomized clinical trials was investigated. Patients were stratified according to revascularization decision making on the basis of iFR or FFR and to clinical presentation (SAP or ACS). The primary endpoint was major adverse cardiac events (MACE), defined as the composite of all-cause death, nonfatal myocardial infarction, or unplanned revascularization at 1 year. RESULTS Coronary revascularization was deferred in 2,130 patients. Deferral was performed in 1,117 patients (50%) in the iFR group and 1,013 patients (45%) in the FFR group (p amp;lt; 0.01). At 1 year, the MACE rate in the deferred population was similar between the iFR and FFR groups (4.12% vs. 4.05%; fully adjusted hazard ratio: 1.13; 95% confidence interval: 0.72 to 1.79; p = 0.60). A clinical presentation with ACS was associated with a higher MACE rate compared with SAP in deferred patients (5.91% vs. 3.64% in ACS and SAP, respectively; fully adjusted hazard ratio: 0.61 in favor of SAP; 95% confidence interval: 0.38 to 0.99; p = 0.04). CONCLUSIONS Overall, deferral of revascularization is equally safe with both iFR and FFR, with a low MACE rate of about 4%. Lesions were more frequently deferred when iFR was used to assess physiological significance. In deferred patients presenting with ACS, the event rate was significantly increased compared with SAP at 1 year. (C) 2018 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation. The aim of this study was to investigate the clinical outcomes of patients deferred from coronary revascularization on the basis of instantaneous wave-free ratio (iFR) or fractional flow reserve (FFR) measurements in stable angina pectoris (SAP) and acute coronary syndromes (ACS). Assessment of coronary stenosis severity with pressure guidewires is recommended to determine the need for myocardial revascularization. The safety of deferral of coronary revascularization in the pooled per-protocol population (n = 4,486) of the DEFINE-FLAIR (Functional Lesion Assessment of Intermediate Stenosis to Guide Revascularisation) and iFR-SWEDEHEART (Instantaneous Wave-Free Ratio Versus Fractional Flow Reserve in Patients With Stable Angina Pectoris or Acute Coronary Syndrome) randomized clinical trials was investigated. Patients were stratified according to revascularization decision making on the basis of iFR or FFR and to clinical presentation (SAP or ACS). The primary endpoint was major adverse cardiac events (MACE), defined as the composite of all-cause death, nonfatal myocardial infarction, or unplanned revascularization at 1 year. Coronary revascularization was deferred in 2,130 patients. Deferral was performed in 1,117 patients (50%) in the iFR group and 1,013 patients (45%) in the FFR group (p < 0.01). At 1 year, the MACE rate in the deferred population was similar between the iFR and FFR groups (4.12% vs. 4.05%; fully adjusted hazard ratio: 1.13; 95% confidence interval: 0.72 to 1.79; p = 0.60). A clinical presentation with ACS was associated with a higher MACE rate compared with SAP in deferred patients (5.91% vs. 3.64% in ACS and SAP, respectively; fully adjusted hazard ratio: 0.61 in favor of SAP; 95% confidence interval: 0.38 to 0.99; p = 0.04). Overall, deferral of revascularization is equally safe with both iFR and FFR, with a low MACE rate of about 4%. Lesions were more frequently deferred when iFR was used to assess physiological significance. In deferred patients presenting with ACS, the event rate was significantly increased compared with SAP at 1 year. [Display omitted] Objectives: The aim of this study was to investigate the clinical outcomes of patients deferred from coronary revascularization on the basis of instantaneous wave-free ratio (iFR) or fractional flow reserve (FFR) measurements in stable angina pectoris (SAP) and acute coronary syndromes (ACS). Background: Assessment of coronary stenosis severity with pressure guidewires is recommended to determine the need for myocardial revascularization. Methods: The safety of deferral of coronary revascularization in the pooled per-protocol population (n = 4,486) of the DEFINE-FLAIR (Functional Lesion Assessment of Intermediate Stenosis to Guide Revascularisation) and iFR-SWEDEHEART (Instantaneous Wave-Free Ratio Versus Fractional Flow Reserve in Patients With Stable Angina Pectoris or Acute Coronary Syndrome) randomized clinical trials was investigated. Patients were stratified according to revascularization decision making on the basis of iFR or FFR and to clinical presentation (SAP or ACS). The primary endpoint was major adverse cardiac events (MACE), defined as the composite of all-cause death, nonfatal myocardial infarction, or unplanned revascularization at 1 year. Results: Coronary revascularization was deferred in 2,130 patients. Deferral was performed in 1,117 patients (50%) in the iFR group and 1,013 patients (45%) in the FFR group (p < 0.01). At 1 year, the MACE rate in the deferred population was similar between the iFR and FFR groups (4.12% vs. 4.05%; fully adjusted hazard ratio: 1.13; 95% confidence interval: 0.72 to 1.79; p = 0.60). A clinical presentation with ACS was associated with a higher MACE rate compared with SAP in deferred patients (5.91% vs. 3.64% in ACS and SAP, respectively; fully adjusted hazard ratio: 0.61 in favor of SAP; 95% confidence interval: 0.38 to 0.99; p = 0.04). Conclusions: Overall, deferral of revascularization is equally safe with both iFR and FFR, with a low MACE rate of about 4%. Lesions were more frequently deferred when iFR was used to assess physiological significance. In deferred patients presenting with ACS, the event rate was significantly increased compared with SAP at 1 year. OBJECTIVES The aim of this study was to investigate the clinical outcomes of patients deferred from coronary revascularization on the basis of instantaneous wave-free ratio (iFR) or fractional flow reserve (FFR) measurements in stable angina pectoris (SAP) and acute coronary syndromes (ACS). BACKGROUND Assessment of coronary stenosis severity with pressure guidewires is recommended to determine the need for myocardial revascularization. METHODS The safety of deferral of coronary revascularization in the pooled per-protocol population (n = 4,486) of the DEFINE-FLAIR (Functional Lesion Assessment of Intermediate Stenosis to Guide Revascularisation) and iFR-SWEDEHEART (Instantaneous Wave-Free Ratio Versus Fractional Flow Reserve in Patients With Stable Angina Pectoris or Acute Coronary Syndrome) randomized clinical trials was investigated. Patients were stratified according to revascularization decision making on the basis of iFR or FFR and to clinical presentation (SAP or ACS). The primary endpoint was major adverse cardiac events (MACE), defined as the composite of all-cause death, nonfatal myocardial infarction, or unplanned revascularization at 1 year. RESULTS Coronary revascularization was deferred in 2,130 patients. Deferral was performed in 1,117 patients (50%) in the iFR group and 1,013 patients (45%) in the FFR group (p < 0.01). At 1 year, the MACE rate in the deferred population was similar between the iFR and FFR groups (4.12% vs. 4.05%; fully adjusted hazard ratio: 1.13; 95% confidence interval: 0.72 to 1.79; p = 0.60). A clinical presentation with ACS was associated with a higher MACE rate compared with SAP in deferred patients (5.91% vs. 3.64% in ACS and SAP, respectively; fully adjusted hazard ratio: 0.61 in favor of SAP; 95% confidence interval: 0.38 to 0.99; p = 0.04). CONCLUSIONS Overall, deferral of revascularization is equally safe with both iFR and FFR, with a low MACE rate of about 4%. Lesions were more frequently deferred when iFR was used to assess physiological significance. In deferred patients presenting with ACS, the event rate was significantly increased compared with SAP at 1 year. The aim of this study was to investigate the clinical outcomes of patients deferred from coronary revascularization on the basis of instantaneous wave-free ratio (iFR) or fractional flow reserve (FFR) measurements in stable angina pectoris (SAP) and acute coronary syndromes (ACS).OBJECTIVESThe aim of this study was to investigate the clinical outcomes of patients deferred from coronary revascularization on the basis of instantaneous wave-free ratio (iFR) or fractional flow reserve (FFR) measurements in stable angina pectoris (SAP) and acute coronary syndromes (ACS).Assessment of coronary stenosis severity with pressure guidewires is recommended to determine the need for myocardial revascularization.BACKGROUNDAssessment of coronary stenosis severity with pressure guidewires is recommended to determine the need for myocardial revascularization.The safety of deferral of coronary revascularization in the pooled per-protocol population (n = 4,486) of the DEFINE-FLAIR (Functional Lesion Assessment of Intermediate Stenosis to Guide Revascularisation) and iFR-SWEDEHEART (Instantaneous Wave-Free Ratio Versus Fractional Flow Reserve in Patients With Stable Angina Pectoris or Acute Coronary Syndrome) randomized clinical trials was investigated. Patients were stratified according to revascularization decision making on the basis of iFR or FFR and to clinical presentation (SAP or ACS). The primary endpoint was major adverse cardiac events (MACE), defined as the composite of all-cause death, nonfatal myocardial infarction, or unplanned revascularization at 1 year.METHODSThe safety of deferral of coronary revascularization in the pooled per-protocol population (n = 4,486) of the DEFINE-FLAIR (Functional Lesion Assessment of Intermediate Stenosis to Guide Revascularisation) and iFR-SWEDEHEART (Instantaneous Wave-Free Ratio Versus Fractional Flow Reserve in Patients With Stable Angina Pectoris or Acute Coronary Syndrome) randomized clinical trials was investigated. Patients were stratified according to revascularization decision making on the basis of iFR or FFR and to clinical presentation (SAP or ACS). The primary endpoint was major adverse cardiac events (MACE), defined as the composite of all-cause death, nonfatal myocardial infarction, or unplanned revascularization at 1 year.Coronary revascularization was deferred in 2,130 patients. Deferral was performed in 1,117 patients (50%) in the iFR group and 1,013 patients (45%) in the FFR group (p < 0.01). At 1 year, the MACE rate in the deferred population was similar between the iFR and FFR groups (4.12% vs. 4.05%; fully adjusted hazard ratio: 1.13; 95% confidence interval: 0.72 to 1.79; p = 0.60). A clinical presentation with ACS was associated with a higher MACE rate compared with SAP in deferred patients (5.91% vs. 3.64% in ACS and SAP, respectively; fully adjusted hazard ratio: 0.61 in favor of SAP; 95% confidence interval: 0.38 to 0.99; p = 0.04).RESULTSCoronary revascularization was deferred in 2,130 patients. Deferral was performed in 1,117 patients (50%) in the iFR group and 1,013 patients (45%) in the FFR group (p < 0.01). At 1 year, the MACE rate in the deferred population was similar between the iFR and FFR groups (4.12% vs. 4.05%; fully adjusted hazard ratio: 1.13; 95% confidence interval: 0.72 to 1.79; p = 0.60). A clinical presentation with ACS was associated with a higher MACE rate compared with SAP in deferred patients (5.91% vs. 3.64% in ACS and SAP, respectively; fully adjusted hazard ratio: 0.61 in favor of SAP; 95% confidence interval: 0.38 to 0.99; p = 0.04).Overall, deferral of revascularization is equally safe with both iFR and FFR, with a low MACE rate of about 4%. Lesions were more frequently deferred when iFR was used to assess physiological significance. In deferred patients presenting with ACS, the event rate was significantly increased compared with SAP at 1 year.CONCLUSIONSOverall, deferral of revascularization is equally safe with both iFR and FFR, with a low MACE rate of about 4%. Lesions were more frequently deferred when iFR was used to assess physiological significance. In deferred patients presenting with ACS, the event rate was significantly increased compared with SAP at 1 year. Objectives: The aim of this study was to investigate the clinical outcomes of patients deferred from coronary revascularization on the basis of instantaneous wave-free ratio (iFR) or fractional flow reserve (FFR) measurements in stable angina pectoris (SAP) and acute coronary syndromes (ACS). Background: Assessment of coronary stenosis severity with pressure guidewires is recommended to determine the need for myocardial revascularization. Methods: The safety of deferral of coronary revascularization in the pooled per-protocol population (n = 4,486) of the DEFINE-FLAIR (Functional Lesion Assessment of Intermediate Stenosis to Guide Revascularisation) and iFR-SWEDEHEART (Instantaneous Wave-Free Ratio Versus Fractional Flow Reserve in Patients With Stable Angina Pectoris or Acute Coronary Syndrome) randomized clinical trials was investigated. Patients were stratified according to revascularization decision making on the basis of iFR or FFR and to clinical presentation (SAP or ACS). The primary endpoint was majoradverse cardiac events (MACE), defined as the composite of all-cause death, nonfatal myocardial infarction, or unplanned revascularization at 1 year. Results: Coronary revascularization was deferred in 2,130 patients. Deferral was performed in 1,117 patients (50%) in the iFR group and 1,013 patients (45%) in the FFR group (p < 0.01). At 1 year, the MACE rate in the deferred population was similar between the iFR and FFR groups (4.12% vs. 4.05%; fully adjusted hazard ratio: 1.13; 95% confidence interval: 0.72 to 1.79; p = 0.60). A clinical presentation with ACS was associated with a higher MACE rate compared with SAP in deferred patients (5.91% vs. 3.64% in ACS and SAP, respectively; fully adjusted hazard ratio: 0.61 in favor of SAP; 95% confidence interval: 0.38 to 0.99; p = 0.04). Conclusions: Overall, deferral of revascularization is equally safe with both iFR and FFR, with a low MACE rate of about 4%. Lesions were more frequently deferred when iFR was used to assess physiological significance. In deferredpatients presenting with ACS, the event rate was significantly increased compared with SAP at 1 year. The aim of this study was to investigate the clinical outcomes of patients deferred from coronary revascularization on the basis of instantaneous wave-free ratio (iFR) or fractional flow reserve (FFR) measurements in stable angina pectoris (SAP) and acute coronary syndromes (ACS). Assessment of coronary stenosis severity with pressure guidewires is recommended to determine the need for myocardial revascularization. The safety of deferral of coronary revascularization in the pooled per-protocol population (n = 4,486) of the DEFINE-FLAIR (Functional Lesion Assessment of Intermediate Stenosis to Guide Revascularisation) and iFR-SWEDEHEART (Instantaneous Wave-Free Ratio Versus Fractional Flow Reserve in Patients With Stable Angina Pectoris or Acute Coronary Syndrome) randomized clinical trials was investigated. Patients were stratified according to revascularization decision making on the basis of iFR or FFR and to clinical presentation (SAP or ACS). The primary endpoint was major adverse cardiac events (MACE), defined as the composite of all-cause death, nonfatal myocardial infarction, or unplanned revascularization at 1 year. Coronary revascularization was deferred in 2,130 patients. Deferral was performed in 1,117 patients (50%) in the iFR group and 1,013 patients (45%) in the FFR group (p < 0.01). At 1 year, the MACE rate in the deferred population was similar between the iFR and FFR groups (4.12% vs. 4.05%; fully adjusted hazard ratio: 1.13; 95% confidence interval: 0.72 to 1.79; p = 0.60). A clinical presentation with ACS was associated with a higher MACE rate compared with SAP in deferred patients (5.91% vs. 3.64% in ACS and SAP, respectively; fully adjusted hazard ratio: 0.61 in favor of SAP; 95% confidence interval: 0.38 to 0.99; p = 0.04). Overall, deferral of revascularization is equally safe with both iFR and FFR, with a low MACE rate of about 4%. Lesions were more frequently deferred when iFR was used to assess physiological significance. In deferred patients presenting with ACS, the event rate was significantly increased compared with SAP at 1 year. |
| Author | Bertilsson, Maria Calais, Fredrik Yokoi, Hiroyoshi Cook, Christopher M. Koul, Sasha Going, Olaf Matsuo, Hitoshi Omerovic, Elmir Serruys, Patrick Vrints, Christiaan J. Sapontis, James Danielewicz, Mikael Hauer, Dario Maeng, Michael Patel, Manesh R. Härle, Tobias Doh, Joon-Hyung Lindroos, Pontus Mejía-Rentería, Hernán Krackhardt, Florian Al-Lamee, Rasha Samuels, Bruce Talwar, Suneel Birgander, Mats Olsson, Sven-Erik Altman, John Kharbanda, Rajesh K. Laine, Mika Nam, Chang-Wook Samady, Habib Walters, Darren Jakobsen, Lars Singh, Jasvindar Jensen, Jens Jeremias, Allen Ryan, Nicola Koo, Bon-Kwon Christiansen, Evald H. Tang, Kare Escaned, Javier Erglis, Andrejs Nijjer, Sukhjinder S. Vinhas, Hugo Meuwissen, Martijn Indolfi, Ciro Ribichini, Flavo Malik, Iqbal S. Götberg, Matthias Dehbi, Hakim-Moulay Di Mario, Carlo Piek, Jan J. Lehman, Sam J. Buller, Christopher Hellig, Farrel Petraco, Ricardo Sandhall, Lennart Seto, Arnold H. Niccoli, Giampaolo Shin, Eun-Seok Takashima, Hiroaki Carlsson, Jörg Olsson, Hans Silva, Pedro Canas Fröbert, Ole Baptista, Sérgio B |
| Author_xml | – sequence: 1 givenname: Javier surname: Escaned fullname: Escaned, Javier organization: Hospital Clínico San Carlos, IDISSC, and Universidad Complutense de Madrid, Madrid, Spain – sequence: 2 givenname: Nicola surname: Ryan fullname: Ryan, Nicola organization: Hospital Clínico San Carlos, IDISSC, and Universidad Complutense de Madrid, Madrid, Spain – sequence: 3 givenname: Hernán surname: Mejía-Rentería fullname: Mejía-Rentería, Hernán organization: Hospital Clínico San Carlos, IDISSC, and Universidad Complutense de Madrid, Madrid, Spain – sequence: 4 givenname: Christopher M. surname: Cook fullname: Cook, Christopher M. organization: Hammersmith Hospital, Imperial College London, London, United Kingdom – sequence: 5 givenname: Hakim-Moulay surname: Dehbi fullname: Dehbi, Hakim-Moulay organization: CRUK & UCL Cancer Trials Centre, University College London, London, United Kingdom – sequence: 6 givenname: Eduardo surname: Alegria-Barrero fullname: Alegria-Barrero, Eduardo organization: Hospital Universitario de Torrejón and Universidad Francisco de Vitoria, Madrid, Spain – sequence: 7 givenname: Ali surname: Alghamdi fullname: Alghamdi, Ali organization: King Abdulaziz Medical City Cardiac Center, Riyadh, Saudi Arabia – sequence: 8 givenname: Rasha surname: Al-Lamee fullname: Al-Lamee, Rasha organization: Hammersmith Hospital, Imperial College London, London, United Kingdom – sequence: 9 givenname: John surname: Altman fullname: Altman, John organization: Colorado Heart and Vascular, Lakewood, Colorado – sequence: 10 givenname: Alphonse surname: Ambrosia fullname: Ambrosia, Alphonse organization: Mesa, Arizona – sequence: 11 givenname: Sérgio B. surname: Baptista fullname: Baptista, Sérgio B. organization: Hospital Prof. Doutor Fernando Fonseca, Amadora, Portugal – sequence: 12 givenname: Maria surname: Bertilsson fullname: Bertilsson, Maria organization: Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden – sequence: 13 givenname: Ravinay surname: Bhindi fullname: Bhindi, Ravinay organization: Royal North Shore Hospital, Sydney, Australia – sequence: 14 givenname: Mats surname: Birgander fullname: Birgander, Mats organization: Department of Cardiology, Clinical Sciences, Lund University, Skåne University Hospital, Lund, Sweden – sequence: 15 givenname: Waldemar surname: Bojara fullname: Bojara, Waldemar organization: Gemeinschaftsklinikum Mittelrhein, Kemperhof Koblenz, Koblenz, Germany – sequence: 16 givenname: Salvatore surname: Brugaletta fullname: Brugaletta, Salvatore organization: Cardiovascular Institute, Hospital Clinic, Institut d’Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain – sequence: 17 givenname: Christopher surname: Buller fullname: Buller, Christopher organization: St. Michaels Hospital, Toronto, Ontario, Canada – sequence: 18 givenname: Fredrik surname: Calais fullname: Calais, Fredrik organization: Department of Cardiology, Faculty of Health, Örebro University, Örebro, Sweden – sequence: 19 givenname: Pedro Canas surname: Silva fullname: Silva, Pedro Canas organization: Hospital Santa Maria, Lisbon, Portugal – sequence: 20 givenname: Jörg surname: Carlsson fullname: Carlsson, Jörg organization: Kalmar County Hospital, and Linnaeus University, Faculty of Health and Life Sciences, Kalmar, Sweden – sequence: 21 givenname: Evald H. surname: Christiansen fullname: Christiansen, Evald H. organization: Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark – sequence: 22 givenname: Mikael surname: Danielewicz fullname: Danielewicz, Mikael organization: Department of Cardiology, Karlstad Hospital, Karlstad, Sweden – sequence: 23 givenname: Carlo surname: Di Mario fullname: Di Mario, Carlo organization: Royal Brompton Hospital, Imperial College London, United Kingdom, and University of Florence, Florence, Italy – sequence: 24 givenname: Joon-Hyung surname: Doh fullname: Doh, Joon-Hyung organization: Inje University Ilsan Paik Hospital, Daehwa-Dong, South Korea – sequence: 25 givenname: Andrejs surname: Erglis fullname: Erglis, Andrejs organization: Pauls Stradins Clinical University Hospital, Riga, Latvia – sequence: 26 givenname: David surname: Erlinge fullname: Erlinge, David organization: Department of Cardiology, Clinical Sciences, Lund University, Skåne University Hospital, Lund, Sweden – sequence: 27 givenname: Robert T. surname: Gerber fullname: Gerber, Robert T. organization: Conquest Hospital, St. Leonards-on-Sea, United Kingdom – sequence: 28 givenname: Olaf surname: Going fullname: Going, Olaf organization: Sana Klinikum Lichtenberg, Lichtenberg, Germany – sequence: 29 givenname: Ingibjörg surname: Gudmundsdottir fullname: Gudmundsdottir, Ingibjörg organization: Department of Cardiology, Reykjavik University Hospital, Reykjavik, Iceland – sequence: 30 givenname: Tobias surname: Härle fullname: Härle, Tobias organization: Klinikum Oldenburg, European Medical School, Carl von Ossietzky University, Oldenburg, Germany – sequence: 31 givenname: Dario surname: Hauer fullname: Hauer, Dario organization: Departments of Cardiology and Medical and Health Sciences, Linköping University, Linköping, Sweden – sequence: 32 givenname: Farrel surname: Hellig fullname: Hellig, Farrel organization: Sunninghill Hospital, Johannesburg, South Africa – sequence: 33 givenname: Ciro surname: Indolfi fullname: Indolfi, Ciro organization: University Magna Graecia, Catanzaro, Italy – sequence: 34 givenname: Lars surname: Jakobsen fullname: Jakobsen, Lars organization: Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark – sequence: 35 givenname: Luc surname: Janssens fullname: Janssens, Luc organization: Imelda Hospital, Bonheiden, Belgium – sequence: 36 givenname: Jens surname: Jensen fullname: Jensen, Jens organization: Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, and Unit of Cardiology, Capio S:t Görans Sjukhus, Stockholm, and Department of Medicine, Sundsvall Hospital, Sundsvall, Sweden – sequence: 37 givenname: Allen surname: Jeremias fullname: Jeremias, Allen organization: Stony Brook University Medical Center, Stony Brook, New York – sequence: 38 givenname: Amra surname: Kåregren fullname: Kåregren, Amra organization: Department of Internal Medicine, Västmanland Hospital Västerås, Västerås, Sweden – sequence: 39 givenname: Ann-Charlotte surname: Karlsson fullname: Karlsson, Ann-Charlotte organization: Department of Cardiology, Halmstad Hospital, Halmstad, Sweden – sequence: 40 givenname: Rajesh K. surname: Kharbanda fullname: Kharbanda, Rajesh K. organization: John Radcliffe Hospital, Oxford University Hospitals Foundation Trust, Oxford, United Kingdom – sequence: 41 givenname: Ahmed surname: Khashaba fullname: Khashaba, Ahmed organization: Ain Shams University, Cairo, Egypt – sequence: 42 givenname: Yuetsu surname: Kikuta fullname: Kikuta, Yuetsu organization: Fukuyama Cardiovascular Hospital, Fukuyama, Japan – sequence: 43 givenname: Florian surname: Krackhardt fullname: Krackhardt, Florian organization: Charite Campus Virchow Klinikum, Universitaetsmedizin, Berlin, Germany – sequence: 44 givenname: Bon-Kwon surname: Koo fullname: Koo, Bon-Kwon organization: Seoul National University Hospital, Seoul, South Korea – sequence: 45 givenname: Sasha surname: Koul fullname: Koul, Sasha organization: Department of Cardiology, Clinical Sciences, Lund University, Skåne University Hospital, Lund, Sweden – sequence: 46 givenname: Mika surname: Laine fullname: Laine, Mika organization: Helsinki University Hospital, Helsinki, Finland – sequence: 47 givenname: Sam J. surname: Lehman fullname: Lehman, Sam J. organization: Flinders University, Adelaide, Australia – sequence: 48 givenname: Pontus surname: Lindroos fullname: Lindroos, Pontus organization: Department of Cardiology, St. Göran Hospital, Stockholm, Sweden – sequence: 49 givenname: Iqbal S. surname: Malik fullname: Malik, Iqbal S. organization: Hammersmith Hospital, Imperial College London, London, United Kingdom – sequence: 50 givenname: Michael surname: Maeng fullname: Maeng, Michael organization: Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark – sequence: 51 givenname: Hitoshi surname: Matsuo fullname: Matsuo, Hitoshi organization: Gifu Heart Center, Gifu, Japan – sequence: 52 givenname: Martijn surname: Meuwissen fullname: Meuwissen, Martijn organization: Amphia Hospital, Breda, the Netherlands – sequence: 53 givenname: Chang-Wook surname: Nam fullname: Nam, Chang-Wook organization: Keimyung University Dongsan Medical Center, Daegu, South Korea – sequence: 54 givenname: Giampaolo surname: Niccoli fullname: Niccoli, Giampaolo organization: Catholic University of the Sacred Heart, Rome, Italy – sequence: 55 givenname: Sukhjinder S. surname: Nijjer fullname: Nijjer, Sukhjinder S. organization: Hammersmith Hospital, Imperial College London, London, United Kingdom – sequence: 56 givenname: Hans surname: Olsson fullname: Olsson, Hans organization: Department of Cardiology, Karlstad Hospital, Karlstad, Sweden – sequence: 57 givenname: Sven-Erik surname: Olsson fullname: Olsson, Sven-Erik organization: Departments of Cardiology and Radiology, Helsingborg Hospital, Helsingborg, Sweden – sequence: 58 givenname: Elmir surname: Omerovic fullname: Omerovic, Elmir organization: Department of Cardiology, Sahlgrenska University Gothenburg, Sweden – sequence: 59 givenname: Georgios surname: Panayi fullname: Panayi, Georgios organization: Departments of Cardiology and Medical and Health Sciences, Linköping University, Linköping, Sweden – sequence: 60 givenname: Ricardo surname: Petraco fullname: Petraco, Ricardo organization: Hammersmith Hospital, Imperial College London, London, United Kingdom – sequence: 61 givenname: Jan J. surname: Piek fullname: Piek, Jan J. organization: AMC Heart Center, Academic Medical Center, Amsterdam, the Netherlands – sequence: 62 givenname: Flavo surname: Ribichini fullname: Ribichini, Flavo organization: University Hospital Verona, Verona, Italy – sequence: 63 givenname: Habib surname: Samady fullname: Samady, Habib organization: Emory University, Atlanta, Georgia – sequence: 64 givenname: Bruce surname: Samuels fullname: Samuels, Bruce organization: Cedars-Sinai Heart Institute, Los Angeles, California – sequence: 65 givenname: Lennart surname: Sandhall fullname: Sandhall, Lennart organization: Departments of Cardiology and Radiology, Helsingborg Hospital, Helsingborg, Sweden – sequence: 66 givenname: James surname: Sapontis fullname: Sapontis, James organization: MonashHeart and Monash University, Melbourne, Australia – sequence: 67 givenname: Sayan surname: Sen fullname: Sen, Sayan organization: Hammersmith Hospital, Imperial College London, London, United Kingdom – sequence: 68 givenname: Arnold H. surname: Seto fullname: Seto, Arnold H. organization: Veterans Affairs Long Beach Healthcare System, Long Beach, California – sequence: 69 givenname: Murat surname: Sezer fullname: Sezer, Murat organization: Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey – sequence: 70 givenname: Andrew S.P. surname: Sharp fullname: Sharp, Andrew S.P. organization: Royal Devon and Exeter Hospital and University of Exeter, Exeter, United Kingdom – sequence: 71 givenname: Eun-Seok surname: Shin fullname: Shin, Eun-Seok organization: Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, South Korea – sequence: 72 givenname: Jasvindar surname: Singh fullname: Singh, Jasvindar organization: Washington University School of Medicine, St. Louis, Missouri – sequence: 73 givenname: Hiroaki surname: Takashima fullname: Takashima, Hiroaki organization: Aichi Medical University Hospital, Aichi, Japan – sequence: 74 givenname: Suneel surname: Talwar fullname: Talwar, Suneel organization: Royal Bournemouth General Hospital, Bournemouth, United Kingdom – sequence: 75 givenname: Nobuhiro surname: Tanaka fullname: Tanaka, Nobuhiro organization: Tokyo Medical University, Tokyo, Japan – sequence: 76 givenname: Kare surname: Tang fullname: Tang, Kare organization: Essex Cardiothoracic Centre, Basildon and Anglia Ruskin University, Chelmsford, United Kingdom – sequence: 77 givenname: Eric surname: Van Belle fullname: Van Belle, Eric organization: Institut Coeur Poumon, Lille University Hospital, and INSERM Unité 1011, Lille, France – sequence: 78 givenname: Niels surname: van Royen fullname: van Royen, Niels organization: VU University Medical Center, Amsterdam, the Netherlands – sequence: 79 givenname: Christoph surname: Varenhorst fullname: Varenhorst, Christoph organization: Department of Medical Sciences, Uppsala University, Uppsala, Sweden – sequence: 80 givenname: Hugo surname: Vinhas fullname: Vinhas, Hugo organization: Hospital Garcia de Horta, Lisbon, Portugal – sequence: 81 givenname: Christiaan J. surname: Vrints fullname: Vrints, Christiaan J. organization: Antwerp University Hospital, Antwerp, Belgium – sequence: 82 givenname: Darren surname: Walters fullname: Walters, Darren organization: Prince Charles Hospital, Brisbane, Australia – sequence: 83 givenname: Hiroyoshi surname: Yokoi fullname: Yokoi, Hiroyoshi organization: Fukuoka Sannou Hospital, Fukuoka, Japan – sequence: 84 givenname: Ole surname: Fröbert fullname: Fröbert, Ole organization: Department of Cardiology, Faculty of Health, Örebro University, Örebro, Sweden – sequence: 85 givenname: Manesh R. surname: Patel fullname: Patel, Manesh R. organization: Duke University, Durham, North Carolina – sequence: 86 givenname: Patrick surname: Serruys fullname: Serruys, Patrick organization: Department of Cardiology, Imperial College London, London, United Kingdom – sequence: 87 givenname: Justin E. surname: Davies fullname: Davies, Justin E. email: justindavies@heart123.com organization: Hammersmith Hospital, Imperial College London, London, United Kingdom – sequence: 88 givenname: Matthias surname: Götberg fullname: Götberg, Matthias organization: Department of Cardiology, Clinical Sciences, Lund University, Skåne University Hospital, Lund, Sweden |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30093050$$D View this record in MEDLINE/PubMed https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-150483$$DView record from Swedish Publication Index https://urn.kb.se/resolve?urn=urn:nbn:se:lnu:diva-77376$$DView record from Swedish Publication Index https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-68506$$DView record from Swedish Publication Index https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-363110$$DView record from Swedish Publication Index https://lup.lub.lu.se/record/6992a4c3-76b3-484e-96b1-93e5a4e52e2a$$DView record from Swedish Publication Index oai:portal.research.lu.se:publications/6992a4c3-76b3-484e-96b1-93e5a4e52e2a$$DView record from Swedish Publication Index http://kipublications.ki.se/Default.aspx?queryparsed=id:138882033$$DView record from Swedish Publication Index |
| BookMark | eNqNk8tu1DAUhiNURC_wAixQlizIYMeJkyA2Q8tApSKklsvScuwT6qnHHnyZanhEngqnM6WoUkslR3ai7_-PdXL-_WzHWANZ9hyjCUaYvp5P5kKZSYlwO0H1BJXdo2wPtw0tGorqnXTuCC3apmt3s33v5whR1DXlk2yXINQRVKO97PcZHyCsczvk4RzyIxjAOa7H90PrrOFunZ_CinsRNXfqFw_KmjytkX7HvfIjemx84CYtsNHn3_kKipkDyE9HPOdG5jPHxShN1jNtL5OnB7eC_BNwHx0swASfK5OfBd5ruKk9dQHSdqR8AuHKaipi-Ic4Wxvp7AL80-zxwLWHZ9v9IPs6e__l8GNx8vnD8eH0pBAtJaGQrZRQ0aHtJeG0QX2F-EBl1QydRCAwh7JEfSu7uoKaQkdEjRvAZd0CkpVsyEFWbHz9JSxjz5ZOLdJFmOWKbT9dpBOwKtXrqsTzO_mldYFr5lI3uBPnTMdRmCitxFWrPaNdV_JKENbQniTPClhHe8w6AjVPVyyh5KnGyZ01dFymp996P9Du1Z12R-rblFn3g8XICCUYo4fh1kVG2xrRh-HaRNY0pKH39vsGV5HhGlUtSfzLDb909mcEH9hCeQFab8aTlaht6o6UJU7oiy0a-wXIv9bX-UhAuwGEs947GJhQ4erHBMeVZhixMYpszsYosjGKDNUsRTFJy1vSa_d7RW83IkgDvFLgmBcKjACpHIjApFX3y9_ckgutTBolfQHr_4n_ACRrZw4 |
| CitedBy_id | crossref_primary_10_4244_EIJ_D_20_01163 crossref_primary_10_1016_j_isci_2023_107245 crossref_primary_10_1016_j_jacasi_2022_03_004 crossref_primary_10_1253_circj_CJ_19_0769 crossref_primary_10_1016_j_ahj_2021_12_018 crossref_primary_10_4244_AIJ_D_22_00022 crossref_primary_10_1016_j_jcin_2020_03_037 crossref_primary_10_1016_j_jcin_2023_07_043 crossref_primary_10_1093_eurheartj_suaa175 crossref_primary_10_1016_j_jcmg_2019_05_025 crossref_primary_10_1016_j_jacc_2023_04_003 crossref_primary_10_1007_s12928_022_00863_1 crossref_primary_10_1093_eurheartj_ehy882 crossref_primary_10_1007_s12928_019_00609_6 crossref_primary_10_1016_j_ijcha_2023_101217 crossref_primary_10_1136_openhrt_2020_001308 crossref_primary_10_1093_ehjcr_ytae325 crossref_primary_10_1177_0003319721996170 crossref_primary_10_1016_j_recesp_2020_12_024 crossref_primary_10_1056_NEJMc2212953 crossref_primary_10_15420_usc_2019_1_1 crossref_primary_10_4244_EIJ_D_20_00988 crossref_primary_10_23736_S2724_5683_21_05628_0 crossref_primary_10_1016_j_iccl_2018_11_003 crossref_primary_10_2459_JCM_0000000000001015 crossref_primary_10_1016_j_carrev_2022_06_254 crossref_primary_10_1016_j_jcin_2018_09_017 crossref_primary_10_4244_EIJ_D_18_00980 crossref_primary_10_1161_CIRCULATIONAHA_121_057793 crossref_primary_10_1016_j_jcin_2020_03_017 crossref_primary_10_1111_eci_14062 crossref_primary_10_1016_j_tcm_2022_01_012 crossref_primary_10_1016_j_ijcard_2021_09_054 crossref_primary_10_1093_cvr_cvad150 crossref_primary_10_1093_eurheartj_ehaa575 crossref_primary_10_1186_s12933_023_01750_6 crossref_primary_10_1016_j_carrev_2023_11_016 crossref_primary_10_1016_j_carrev_2023_01_027 crossref_primary_10_1016_j_carrev_2023_03_019 crossref_primary_10_1001_jamacardio_2024_3314 crossref_primary_10_1002_ccd_30342 crossref_primary_10_1016_j_jscai_2023_101046 crossref_primary_10_1055_a_2156_7872 crossref_primary_10_1016_j_cmpb_2024_108355 crossref_primary_10_1016_j_tcm_2019_08_011 crossref_primary_10_1007_s10554_023_02967_y crossref_primary_10_1016_j_jcin_2020_03_027 crossref_primary_10_4244_EIJ_D_24_01001 crossref_primary_10_1161_CIRCINTERVENTIONS_121_011387 crossref_primary_10_3389_fcvm_2021_744181 crossref_primary_10_1007_s12471_020_01461_7 crossref_primary_10_2459_JCM_0000000000001264 crossref_primary_10_1002_ccd_29823 crossref_primary_10_1093_eurheartjsupp_suae034 crossref_primary_10_1371_journal_pone_0237275 crossref_primary_10_17116_Cardiobulletin20241903143 crossref_primary_10_1016_j_jacc_2023_03_409 crossref_primary_10_1161_CIR_0000000000001038 crossref_primary_10_1093_eurheartj_ehaa481 crossref_primary_10_1038_s41569_024_01014_0 crossref_primary_10_4244_EIJ_D_20_00957 crossref_primary_10_1016_j_jcin_2019_04_017 crossref_primary_10_1016_j_jcin_2022_02_022 crossref_primary_10_1093_ejcts_ezae271 crossref_primary_10_15836_ccar2022_223 crossref_primary_10_3390_medicina60040549 crossref_primary_10_1016_j_ahj_2019_09_014 crossref_primary_10_1016_j_jcin_2018_06_025 crossref_primary_10_1016_j_ijcard_2024_132726 crossref_primary_10_2174_1573403X17666210908114154 crossref_primary_10_1016_j_jcin_2018_09_004 crossref_primary_10_1007_s11886_019_1233_6 crossref_primary_10_1161_JAHA_118_011534 crossref_primary_10_1161_CIR_0000000000001168 crossref_primary_10_1161_JAHA_120_018344 crossref_primary_10_1177_02676591221099808 crossref_primary_10_1002_ccd_30480 crossref_primary_10_1016_j_jcin_2019_06_035 crossref_primary_10_1007_s00392_021_01897_w crossref_primary_10_4244_EIJV14I8A152 crossref_primary_10_1016_j_jcin_2020_04_040 crossref_primary_10_3390_fluids4020060 crossref_primary_10_1016_j_jacc_2021_12_030 crossref_primary_10_15836_ccar2023_79 crossref_primary_10_1161_JAHA_122_028423 crossref_primary_10_1136_bmjopen_2020_044035 crossref_primary_10_1007_s00059_019_04878_y crossref_primary_10_1161_JAHA_119_012456 crossref_primary_10_1007_s11886_019_1105_0 crossref_primary_10_1007_s11936_020_0803_7 crossref_primary_10_1161_HCQ_0000000000000121 crossref_primary_10_23736_S0031_0808_21_04363_9 crossref_primary_10_1002_ccr3_3197 crossref_primary_10_1016_j_jcin_2019_06_044 crossref_primary_10_1007_s12471_023_01796_x crossref_primary_10_3389_fcvm_2022_969060 crossref_primary_10_1016_j_jscai_2024_102198 crossref_primary_10_1253_circj_CJ_19_0230 crossref_primary_10_1016_j_jcin_2021_10_031 crossref_primary_10_1016_j_ahj_2023_05_017 crossref_primary_10_1007_s40119_023_00329_2 crossref_primary_10_1136_openhrt_2018_000934 crossref_primary_10_26442_00403660_2023_04_202169 crossref_primary_10_1002_ccd_30025 crossref_primary_10_1093_eurheartj_ehae177 crossref_primary_10_1016_j_carrev_2023_10_015 crossref_primary_10_1016_j_carrev_2021_07_007 crossref_primary_10_1016_j_jcin_2018_10_034 crossref_primary_10_1016_j_jcin_2020_06_018 crossref_primary_10_1038_s41569_020_0374_z crossref_primary_10_1016_j_jacc_2021_09_006 |
| Cites_doi | 10.1016/j.jcin.2011.08.008 10.4244/EIJ-D-17-00110 10.1016/j.jacc.2010.04.012 10.1056/NEJMoa1701067 10.1016/S0140-6736(15)60648-1 10.1161/01.CIR.103.24.2928 10.1016/j.jacc.2016.06.035 10.1056/NEJMoa1700445 10.1056/NEJMoa1616540 10.1093/eurheartj/ehu278 10.1016/j.jcin.2015.01.029 10.1161/JAHA.115.002172 10.1093/eurheartj/ehv452 10.1161/CIRCULATIONAHA.113.006646 10.1016/j.jacc.2014.07.987 10.1161/CIRCULATIONAHA.116.024433 10.1161/CIRCINTERVENTIONS.116.004296 10.1161/CIRCULATIONAHA.113.003583 10.1016/j.ahj.2017.01.016 10.1016/j.ahj.2014.06.022 10.1056/NEJMe1702728 10.1093/eurheartj/ehu094 10.1161/CIRCRESAHA.114.302699 10.1056/NEJMoa1408758 10.1056/NEJMoa0807611 |
| ContentType | Journal Article |
| Copyright | 2018 The Authors Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved. |
| Copyright_xml | – notice: 2018 The Authors – notice: Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved. |
| CorporateAuthor | Kardiologi Department of Clinical Sciences, Lund Molekylär kardiologi Molecular Cardiology Faculty of Medicine Institutionen för kliniska vetenskaper, Lund Sektion II Section II Lunds universitet Medicinska fakulteten Lund University Cardiology |
| CorporateAuthor_xml | – name: Faculty of Medicine – name: Department of Clinical Sciences, Lund – name: Medicinska fakulteten – name: Sektion II – name: Molekylär kardiologi – name: Kardiologi – name: Section II – name: Lund University – name: Cardiology – name: Institutionen för kliniska vetenskaper, Lund – name: Molecular Cardiology – name: Lunds universitet |
| DBID | 6I. AAFTH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 ABXSW ADTPV AOWAS D8T DG8 ZZAVC AGRUY D92 AABEP D91 ACNBI DF2 AGCHP D95 |
| DOI | 10.1016/j.jcin.2018.05.029 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic SWEPUB Linköpings universitet full text SwePub SwePub Articles SWEPUB Freely available online SWEPUB Linköpings universitet SwePub Articles full text SWEPUB Linnéuniversitetet full text SWEPUB Linnéuniversitetet SWEPUB Örebro universitet full text SWEPUB Örebro universitet SWEPUB Uppsala universitet full text SWEPUB Uppsala universitet SWEPUB Lunds universitet full text SWEPUB Lunds universitet |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Nursing |
| EISSN | 1876-7605 |
| EndPage | 1449 |
| ExternalDocumentID | oai_swepub_ki_se_486394 oai_portal_research_lu_se_publications_6992a4c3_76b3_484e_96b1_93e5a4e52e2a oai_lup_lub_lu_se_6992a4c3_76b3_484e_96b1_93e5a4e52e2a oai_DiVA_org_uu_363110 oai_DiVA_org_oru_68506 oai_DiVA_org_lnu_77376 oai_DiVA_org_liu_150483 30093050 10_1016_j_jcin_2018_05_029 S1936879818311439 |
| Genre | Multicenter Study Comparative Study Research Support, Non-U.S. Gov't Journal Article |
| GrantInformation_xml | – fundername: Medical Research Council grantid: G1100443 – fundername: Medical Research Council grantid: MR/M018369/1 |
| GroupedDBID | --- --K --M .1- .FO .~1 0R~ 18M 1B1 1P~ 1~. 4.4 457 4G. 53G 5GY 5VS 7-5 8P~ AAEDW AAIKJ AALRI AAOAW AAQFI AAXUO AAYWO ABBQC ABFRF ABJNI ABMAC ABMZM ACGFO ACGFS ADBBV ADEZE ADVLN AEFWE AEKER AEVXI AEXQZ AFJKZ AFRHN AFTJW AGCQF AGYEJ AITUG AJRQY ALMA_UNASSIGNED_HOLDINGS AMRAJ BAWUL BLXMC CS3 DIK EBS EFKBS EJD F5P FDB FEDTE FNPLU GBLVA H13 HVGLF IXB J1W M41 MO0 N9A O-L O9- OAUVE OA~ OK1 OL0 P-8 P-9 P2P PC. Q38 ROL SDF SEL SES SSZ W8F Z5R 6I. AACTN AAFTH AAIAV ABVKL AFCTW AJOXV AMFUW EFLBG LCYCR NCXOZ RIG T5K ZA5 AAEDT AAYXX ABWVN ABXDB ACRPL ADMUD ADNMO AFETI AGHFR APXCP CITATION HZ~ CGR CUY CVF ECM EIF NPM 7X8 ABXSW ADTPV AOWAS D8T DG8 ZZAVC AGRUY D92 AABEP D91 ACNBI DF2 AGCHP D95 |
| ID | FETCH-LOGICAL-c863t-d8dde46f8bd3a670b40af6d47f9d0ec1ae220b8d954e56e93c517e1258e0d4d73 |
| IEDL.DBID | IXB |
| ISSN | 1936-8798 1876-7605 |
| IngestDate | Mon Sep 01 03:33:03 EDT 2025 Thu Aug 21 06:35:10 EDT 2025 Thu Jul 03 05:16:56 EDT 2025 Thu Aug 21 06:48:49 EDT 2025 Thu Aug 21 06:17:02 EDT 2025 Wed Sep 03 03:32:47 EDT 2025 Thu Aug 21 06:15:40 EDT 2025 Fri Jul 11 06:03:57 EDT 2025 Mon Jul 21 06:08:02 EDT 2025 Thu Apr 24 23:10:51 EDT 2025 Tue Jul 01 01:31:00 EDT 2025 Fri Feb 23 02:47:47 EST 2024 Tue Aug 26 20:09:42 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 15 |
| Keywords | ACS deferral of revascularization FFR SAP iFR MACE CI PCI HR MI coronary physiology |
| Language | English |
| License | This is an open access article under the CC BY-NC-ND license. Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c863t-d8dde46f8bd3a670b40af6d47f9d0ec1ae220b8d954e56e93c517e1258e0d4d73 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
| OpenAccessLink | https://www.sciencedirect.com/science/article/pii/S1936879818311439 |
| PMID | 30093050 |
| PQID | 2087593221 |
| PQPubID | 23479 |
| PageCount | 13 |
| ParticipantIDs | swepub_primary_oai_swepub_ki_se_486394 swepub_primary_oai_portal_research_lu_se_publications_6992a4c3_76b3_484e_96b1_93e5a4e52e2a swepub_primary_oai_lup_lub_lu_se_6992a4c3_76b3_484e_96b1_93e5a4e52e2a swepub_primary_oai_DiVA_org_uu_363110 swepub_primary_oai_DiVA_org_oru_68506 swepub_primary_oai_DiVA_org_lnu_77376 swepub_primary_oai_DiVA_org_liu_150483 proquest_miscellaneous_2087593221 pubmed_primary_30093050 crossref_citationtrail_10_1016_j_jcin_2018_05_029 crossref_primary_10_1016_j_jcin_2018_05_029 elsevier_sciencedirect_doi_10_1016_j_jcin_2018_05_029 elsevier_clinicalkey_doi_10_1016_j_jcin_2018_05_029 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2018-08-13 |
| PublicationDateYYYYMMDD | 2018-08-13 |
| PublicationDate_xml | – month: 08 year: 2018 text: 2018-08-13 day: 13 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | JACC. Cardiovascular interventions |
| PublicationTitleAlternate | JACC Cardiovasc Interv |
| PublicationYear | 2018 |
| Publisher | Elsevier Inc |
| Publisher_xml | – name: Elsevier Inc |
| References | Toth, Hamilos, Pyxaras (bib17) 2014; 35 Götberg, Christiansen, Gudmundsdottir (bib7) 2017; 376 Pijls, Fearon, Tonino (bib19) 2010; 56 Escaned, Echavarría-Pinto, Garcia-Garcia (bib8) 2015; 8 Libby, Tabas, Fredman, Fisher (bib24) 2014; 114 Smits, Abdel-Wahab, Neumann (bib11) 2017; 376 Lee, Choi, Koo (bib15) 2017; 13 Petraco, Al-Lamee, Gotberg (bib10) 2014; 168 Cuculi, De Maria, Meier (bib25) 2014; 64 Davies, Sen, Dehbi (bib6) 2017; 376 Hess, Clare, Neely (bib23) 2017; 187 Bhatt (bib18) 2017; 376 Sels, Tonino, Siebert (bib21) 2011; 4 De Bruyne, Fearon, Pijls (bib16) 2014; 371 Arbab-Zadeh (bib5) 2014; 129 Van Belle, Rioufol, Pouillot (bib9) 2014; 129 Zimmermann, Ferrara, Johnson (bib4) 2015; 36 Masrani Mehta, Depta, Novak (bib13) 2015; 4 Tonino, De Bruyne, Pijls (bib2) 2009; 360 Bech, De Bruyne, Pijls (bib3) 2001; 103 Belle, Baptista, Raposo (bib22) 2017; 10 Engstrøm, Kelbæk, Helqvist (bib12) 2015; 386 Hakeem, Edupuganti, Almomani (bib14) 2016; 68 Windecker, Kohl, Alfonso (bib1) 2014; 35 Ahn, Park, Shin (bib20) 2017; 135 Zimmermann (10.1016/j.jcin.2018.05.029_bib4) 2015; 36 Lee (10.1016/j.jcin.2018.05.029_bib15) 2017; 13 Ahn (10.1016/j.jcin.2018.05.029_bib20) 2017; 135 Davies (10.1016/j.jcin.2018.05.029_bib6) 2017; 376 Bhatt (10.1016/j.jcin.2018.05.029_bib18) 2017; 376 Sels (10.1016/j.jcin.2018.05.029_bib21) 2011; 4 Smits (10.1016/j.jcin.2018.05.029_bib11) 2017; 376 Bech (10.1016/j.jcin.2018.05.029_bib3) 2001; 103 Arbab-Zadeh (10.1016/j.jcin.2018.05.029_bib5) 2014; 129 Pijls (10.1016/j.jcin.2018.05.029_bib19) 2010; 56 Petraco (10.1016/j.jcin.2018.05.029_bib10) 2014; 168 Belle (10.1016/j.jcin.2018.05.029_bib22) 2017; 10 Escaned (10.1016/j.jcin.2018.05.029_bib8) 2015; 8 Engstrøm (10.1016/j.jcin.2018.05.029_bib12) 2015; 386 Libby (10.1016/j.jcin.2018.05.029_bib24) 2014; 114 Hess (10.1016/j.jcin.2018.05.029_bib23) 2017; 187 Windecker (10.1016/j.jcin.2018.05.029_bib1) 2014; 35 Götberg (10.1016/j.jcin.2018.05.029_bib7) 2017; 376 De Bruyne (10.1016/j.jcin.2018.05.029_bib16) 2014; 371 Cuculi (10.1016/j.jcin.2018.05.029_bib25) 2014; 64 Tonino (10.1016/j.jcin.2018.05.029_bib2) 2009; 360 Hakeem (10.1016/j.jcin.2018.05.029_bib14) 2016; 68 Van Belle (10.1016/j.jcin.2018.05.029_bib9) 2014; 129 Toth (10.1016/j.jcin.2018.05.029_bib17) 2014; 35 Masrani Mehta (10.1016/j.jcin.2018.05.029_bib13) 2015; 4 30522675 - JACC Cardiovasc Interv. 2018 Dec 10;11(23):2433-2434. doi: 10.1016/j.jcin.2018.09.004. 30522678 - JACC Cardiovasc Interv. 2018 Dec 10;11(23):2435. doi: 10.1016/j.jcin.2018.10.034. 30093051 - JACC Cardiovasc Interv. 2018 Aug 13;11(15):1450-1453. doi: 10.1016/j.jcin.2018.06.025. 30522676 - JACC Cardiovasc Interv. 2018 Dec 10;11(23):2434. doi: 10.1016/j.jcin.2018.09.017. |
| References_xml | – volume: 129 start-page: 173 year: 2014 end-page: 185 ident: bib9 article-title: Outcome impact of coronary revascularization strategy reclassification with fractional flow reserve at time of diagnostic angiography: insights from a large French multicenter fractional flow reserve registry publication-title: Circulation – volume: 56 start-page: 177 year: 2010 end-page: 184 ident: bib19 article-title: Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study publication-title: J Am Coll Cardiol – volume: 4 start-page: e002172 year: 2015 ident: bib13 article-title: Association of lower fractional flow reserve values with higher risk of adverse cardiac events for lesions deferred revascularization among patients with acute coronary syndrome publication-title: J Am Heart Assoc – volume: 64 start-page: 1894 year: 2014 end-page: 1904 ident: bib25 article-title: Impact of microvascular obstruction on the assessment of coronary flow reserve, index of microcirculatory resistance, and fractional flow reserve after publication-title: J Am Coll Cardiol – volume: 376 start-page: 1234 year: 2017 end-page: 1244 ident: bib11 article-title: Fractional flow reserve–guided multivessel angioplasty in myocardial infarction publication-title: N Engl J Med – volume: 376 start-page: 1813 year: 2017 end-page: 1823 ident: bib7 article-title: Instantaneous wave-free ratio versus fractional flow reserve to guide PCI publication-title: N Engl J Med – volume: 168 start-page: 739 year: 2014 end-page: 748 ident: bib10 article-title: Real-time use of instantaneous wave-free ratio: results of the ADVISE in-practice: an international, multicenter evaluation of instantaneous wave-free ratio in clinical practice publication-title: Am Heart J – volume: 13 start-page: e1112 year: 2017 end-page: e1119 ident: bib15 article-title: Prognosis of deferred non-culprit lesions according to fractional flow reserve in patients with acute coronary syndrome publication-title: EuroIntervention – volume: 36 start-page: 3182 year: 2015 end-page: 3188 ident: bib4 article-title: Deferral vs. performance of percutaneous coronary intervention of functionally non-significant coronary stenosis: 15-year follow-up of the DEFER trial publication-title: Eur Heart J – volume: 10 start-page: e004296 year: 2017 ident: bib22 article-title: Impact of routine fractional flow reserve on management decision and 1-year clinical outcome of patients with acute coronary syndromes publication-title: Circ Cardiovasc Interv – volume: 376 start-page: 1879 year: 2017 end-page: 1881 ident: bib18 article-title: Assessment of stable coronary lesions publication-title: N Engl J Med – volume: 135 start-page: 2241 year: 2017 end-page: 2251 ident: bib20 article-title: Fractional flow reserve and cardiac events in coronary artery disease: data from a prospective IRIS-FFR registry (Interventional Cardiology Research Incooperation Society Fractional Flow Reserve) publication-title: Circulation – volume: 35 start-page: 2831 year: 2014 end-page: 2838 ident: bib17 article-title: Evolving concepts of angiogram: fractional flow reserve discordances in 4000 coronary stenoses publication-title: Eur Heart J – volume: 187 start-page: 194 year: 2017 end-page: 203 ident: bib23 article-title: Differential occurrence, profile, and impact of first recurrent cardiovascular events after an acute coronary syndrome publication-title: Am Heart J – volume: 360 start-page: 213 year: 2009 end-page: 224 ident: bib2 article-title: Fractional flow reserve versus angiography for guiding percutaneous coronary intervention publication-title: N Engl J Med – volume: 35 start-page: 2541 year: 2014 end-page: 2619 ident: bib1 article-title: 2014 ESC/EACTS guidelines on myocardial revascularization publication-title: Eur Heart J – volume: 376 start-page: 1824 year: 2017 end-page: 1834 ident: bib6 article-title: Use of the instantaneous wave-free ratio or fractional flow reserve in PCI publication-title: N Engl J Med – volume: 371 start-page: 1208 year: 2014 end-page: 1217 ident: bib16 article-title: Fractional flow reserve-guided PCI for stable coronary artery disease publication-title: N Engl J Med – volume: 386 start-page: 665 year: 2015 end-page: 671 ident: bib12 article-title: Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial publication-title: Lancet – volume: 114 start-page: 1867 year: 2014 end-page: 1879 ident: bib24 article-title: Inflammation and its resolution as determinants of acute coronary syndromes publication-title: Circ Res – volume: 103 start-page: 2928 year: 2001 end-page: 2934 ident: bib3 article-title: Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: a randomized trial publication-title: Circulation – volume: 8 start-page: 824 year: 2015 end-page: 833 ident: bib8 article-title: Prospective assessment of the diagnostic accuracy of instantaneous wave-free ratio to assess coronary stenosis relevance: results of ADVISE II international, multicenter study (Adenosine Vasodilator Independent Stenosis Evaluation II) publication-title: J Am Coll Cardiol Intv – volume: 4 start-page: 1183 year: 2011 end-page: 1189 ident: bib21 article-title: Fractional flow reserve in unstable angina and non-ST-segment elevation myocardial infarction experience from the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study publication-title: J Am Coll Cardiol Intv – volume: 129 start-page: 1871 year: 2014 end-page: 1878 ident: bib5 article-title: Fractional flow reserve-guided percutaneous coronary intervention is not a valid concept publication-title: Circulation – volume: 68 start-page: 1181 year: 2016 end-page: 1191 ident: bib14 article-title: Long-term prognosis of deferred acute coronary syndrome lesions based on nonischemic fractional flow reserve publication-title: J Am Coll Cardiol – volume: 4 start-page: 1183 year: 2011 ident: 10.1016/j.jcin.2018.05.029_bib21 article-title: Fractional flow reserve in unstable angina and non-ST-segment elevation myocardial infarction experience from the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study publication-title: J Am Coll Cardiol Intv doi: 10.1016/j.jcin.2011.08.008 – volume: 13 start-page: e1112 year: 2017 ident: 10.1016/j.jcin.2018.05.029_bib15 article-title: Prognosis of deferred non-culprit lesions according to fractional flow reserve in patients with acute coronary syndrome publication-title: EuroIntervention doi: 10.4244/EIJ-D-17-00110 – volume: 56 start-page: 177 year: 2010 ident: 10.1016/j.jcin.2018.05.029_bib19 article-title: Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2010.04.012 – volume: 376 start-page: 1234 year: 2017 ident: 10.1016/j.jcin.2018.05.029_bib11 article-title: Fractional flow reserve–guided multivessel angioplasty in myocardial infarction publication-title: N Engl J Med doi: 10.1056/NEJMoa1701067 – volume: 386 start-page: 665 year: 2015 ident: 10.1016/j.jcin.2018.05.029_bib12 article-title: Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial publication-title: Lancet doi: 10.1016/S0140-6736(15)60648-1 – volume: 103 start-page: 2928 year: 2001 ident: 10.1016/j.jcin.2018.05.029_bib3 article-title: Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: a randomized trial publication-title: Circulation doi: 10.1161/01.CIR.103.24.2928 – volume: 68 start-page: 1181 year: 2016 ident: 10.1016/j.jcin.2018.05.029_bib14 article-title: Long-term prognosis of deferred acute coronary syndrome lesions based on nonischemic fractional flow reserve publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2016.06.035 – volume: 376 start-page: 1824 year: 2017 ident: 10.1016/j.jcin.2018.05.029_bib6 article-title: Use of the instantaneous wave-free ratio or fractional flow reserve in PCI publication-title: N Engl J Med doi: 10.1056/NEJMoa1700445 – volume: 376 start-page: 1813 year: 2017 ident: 10.1016/j.jcin.2018.05.029_bib7 article-title: Instantaneous wave-free ratio versus fractional flow reserve to guide PCI publication-title: N Engl J Med doi: 10.1056/NEJMoa1616540 – volume: 35 start-page: 2541 year: 2014 ident: 10.1016/j.jcin.2018.05.029_bib1 article-title: 2014 ESC/EACTS guidelines on myocardial revascularization publication-title: Eur Heart J doi: 10.1093/eurheartj/ehu278 – volume: 8 start-page: 824 year: 2015 ident: 10.1016/j.jcin.2018.05.029_bib8 article-title: Prospective assessment of the diagnostic accuracy of instantaneous wave-free ratio to assess coronary stenosis relevance: results of ADVISE II international, multicenter study (Adenosine Vasodilator Independent Stenosis Evaluation II) publication-title: J Am Coll Cardiol Intv doi: 10.1016/j.jcin.2015.01.029 – volume: 4 start-page: e002172 year: 2015 ident: 10.1016/j.jcin.2018.05.029_bib13 article-title: Association of lower fractional flow reserve values with higher risk of adverse cardiac events for lesions deferred revascularization among patients with acute coronary syndrome publication-title: J Am Heart Assoc doi: 10.1161/JAHA.115.002172 – volume: 36 start-page: 3182 year: 2015 ident: 10.1016/j.jcin.2018.05.029_bib4 article-title: Deferral vs. performance of percutaneous coronary intervention of functionally non-significant coronary stenosis: 15-year follow-up of the DEFER trial publication-title: Eur Heart J doi: 10.1093/eurheartj/ehv452 – volume: 129 start-page: 173 year: 2014 ident: 10.1016/j.jcin.2018.05.029_bib9 article-title: Outcome impact of coronary revascularization strategy reclassification with fractional flow reserve at time of diagnostic angiography: insights from a large French multicenter fractional flow reserve registry publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.113.006646 – volume: 64 start-page: 1894 year: 2014 ident: 10.1016/j.jcin.2018.05.029_bib25 article-title: Impact of microvascular obstruction on the assessment of coronary flow reserve, index of microcirculatory resistance, and fractional flow reserve after publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2014.07.987 – volume: 135 start-page: 2241 year: 2017 ident: 10.1016/j.jcin.2018.05.029_bib20 article-title: Fractional flow reserve and cardiac events in coronary artery disease: data from a prospective IRIS-FFR registry (Interventional Cardiology Research Incooperation Society Fractional Flow Reserve) publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.116.024433 – volume: 10 start-page: e004296 year: 2017 ident: 10.1016/j.jcin.2018.05.029_bib22 article-title: Impact of routine fractional flow reserve on management decision and 1-year clinical outcome of patients with acute coronary syndromes publication-title: Circ Cardiovasc Interv doi: 10.1161/CIRCINTERVENTIONS.116.004296 – volume: 129 start-page: 1871 year: 2014 ident: 10.1016/j.jcin.2018.05.029_bib5 article-title: Fractional flow reserve-guided percutaneous coronary intervention is not a valid concept publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.113.003583 – volume: 187 start-page: 194 year: 2017 ident: 10.1016/j.jcin.2018.05.029_bib23 article-title: Differential occurrence, profile, and impact of first recurrent cardiovascular events after an acute coronary syndrome publication-title: Am Heart J doi: 10.1016/j.ahj.2017.01.016 – volume: 168 start-page: 739 year: 2014 ident: 10.1016/j.jcin.2018.05.029_bib10 article-title: Real-time use of instantaneous wave-free ratio: results of the ADVISE in-practice: an international, multicenter evaluation of instantaneous wave-free ratio in clinical practice publication-title: Am Heart J doi: 10.1016/j.ahj.2014.06.022 – volume: 376 start-page: 1879 year: 2017 ident: 10.1016/j.jcin.2018.05.029_bib18 article-title: Assessment of stable coronary lesions publication-title: N Engl J Med doi: 10.1056/NEJMe1702728 – volume: 35 start-page: 2831 year: 2014 ident: 10.1016/j.jcin.2018.05.029_bib17 article-title: Evolving concepts of angiogram: fractional flow reserve discordances in 4000 coronary stenoses publication-title: Eur Heart J doi: 10.1093/eurheartj/ehu094 – volume: 114 start-page: 1867 year: 2014 ident: 10.1016/j.jcin.2018.05.029_bib24 article-title: Inflammation and its resolution as determinants of acute coronary syndromes publication-title: Circ Res doi: 10.1161/CIRCRESAHA.114.302699 – volume: 371 start-page: 1208 year: 2014 ident: 10.1016/j.jcin.2018.05.029_bib16 article-title: Fractional flow reserve-guided PCI for stable coronary artery disease publication-title: N Engl J Med doi: 10.1056/NEJMoa1408758 – volume: 360 start-page: 213 year: 2009 ident: 10.1016/j.jcin.2018.05.029_bib2 article-title: Fractional flow reserve versus angiography for guiding percutaneous coronary intervention publication-title: N Engl J Med doi: 10.1056/NEJMoa0807611 – reference: 30522676 - JACC Cardiovasc Interv. 2018 Dec 10;11(23):2434. doi: 10.1016/j.jcin.2018.09.017. – reference: 30522675 - JACC Cardiovasc Interv. 2018 Dec 10;11(23):2433-2434. doi: 10.1016/j.jcin.2018.09.004. – reference: 30522678 - JACC Cardiovasc Interv. 2018 Dec 10;11(23):2435. doi: 10.1016/j.jcin.2018.10.034. – reference: 30093051 - JACC Cardiovasc Interv. 2018 Aug 13;11(15):1450-1453. doi: 10.1016/j.jcin.2018.06.025. |
| SSID | ssj0060972 |
| Score | 2.5528748 |
| Snippet | The aim of this study was to investigate the clinical outcomes of patients deferred from coronary revascularization on the basis of instantaneous wave-free... OBJECTIVES The aim of this study was to investigate the clinical outcomes of patients deferred from coronary revascularization on the basis of instantaneous... OBJECTIVES: The aim of this study was to investigate the clinical outcomes of patients deferred from coronary revascularization on the basis of instantaneous... Objectives: The aim of this study was to investigate the clinical outcomes of patients deferred from coronary revascularization on the basis of instantaneous... |
| SourceID | swepub proquest pubmed crossref elsevier |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1437 |
| SubjectTerms | ACS Acute Coronary Syndrome - diagnosis Acute Coronary Syndrome - physiopathology Acute Coronary Syndrome - therapy Aged Angina, Stable - diagnosis Angina, Stable - physiopathology Angina, Stable - therapy Cardiac and Cardiovascular Systems Cardiac Catheterization Cardiology and Cardiovascular Disease Clinical Decision-Making Clinical Medicine Coronary Artery Disease - diagnosis Coronary Artery Disease - physiopathology Coronary Artery Disease - therapy coronary physiology Coronary Stenosis - diagnosis Coronary Stenosis - physiopathology Coronary Stenosis - therapy deferral of revascularization Female FFR Fractional Flow Reserve, Myocardial Humans iFR Kardiologi Kardiologi och kardiovaskulära sjukdomar Klinisk medicin Male Medical and Health Sciences Medicin och hälsovetenskap Middle Aged Myocardial Revascularization - adverse effects Nursing Omvårdnad Patient Selection Predictive Value of Tests Randomized Controlled Trials as Topic Risk Factors SAP Time Factors Time-to-Treatment Treatment Outcome |
| Title | Safety of the Deferral of Coronary Revascularization on the Basis of Instantaneous Wave-Free Ratio and Fractional Flow Reserve Measurements in Stable Coronary Artery Disease and Acute Coronary Syndromes |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S1936879818311439 https://dx.doi.org/10.1016/j.jcin.2018.05.029 https://www.ncbi.nlm.nih.gov/pubmed/30093050 https://www.proquest.com/docview/2087593221 https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-150483 https://urn.kb.se/resolve?urn=urn:nbn:se:lnu:diva-77376 https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-68506 https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-363110 https://lup.lub.lu.se/record/6992a4c3-76b3-484e-96b1-93e5a4e52e2a oai:portal.research.lu.se:publications/6992a4c3-76b3-484e-96b1-93e5a4e52e2a http://kipublications.ki.se/Default.aspx?queryparsed=id:138882033 |
| Volume | 11 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfGHhAviG_Cx2Qk4AWFJnFiO49du2oDlYeVQcWL5SSXkVG1VdoM9YU_kL-Kc-J0A6oWISWV4p4vVu5894t9dyHkJWjBwPNTF82jdsNAB67mMndTEWkR6wS9ulmHHH7gx2fhu3E03iO9NhfGhFVa29_Y9Npa25aOfZqdeVF0Rgg9uBQxehyGoJ6ZJD4WyjqJb3zYWmNuytM0O8vcNdQ2caaJ8bpIC1MD1Zd19c4aZm50Tn-Dzz8qi9beaHCH3LYwknabkd4lezC9R24O7Ub5ffJzpHNYrugsp4jwaN-Uky2xA173TM0CXa7oKbRhqDYXk-JhqA_1olgY0pMaO-IBs2pBP-tLcAclAD015FRPMzoom8QIZD2YzL5TE8hXXgIdXi09LmgxpYhpkwlc3btrIklXtN9sD9Wsumm1vEYxsqUUFg_I2eDoY-_YtZ9tcFPJ2dLNJJrMkOcyyZjmwktCT-c8C0UeZx6kvoYg8BKZoRZAxCFmaeQLQKAlwcvCTLCHZH86m8JjQv00lp5mIgCNSCMLdCJ0ljOZeoBtsXSI38pLpbamufm0xkS1wWsXyshYGRkrL1IoY4e8WfeZNxU9tlKzVg1Um6uK1lWhw9naK1r3-k2bd_Z70Wqawmlu9m4aESMRvlgi1g58hzxqVHA9emaWpbzIc8jrRifX_5ja4f3iU1fNynM1KSqF8B-niENebSWcVkoI9Dw76GZlpbipeLiDrqoU4zhHcYBHG-gm1RzPBE-1AMXjONBhypTgCVOhDEHFPPFVzCDSqDABBNohXzbwad5XlS2S9dXym19b_f5H5pueom36VhieIep5HD75TyE_JbfMldmY8Nkzsr8sK3iOyHaZHJAbb3_4-Ns_eX9Qm7Ffi4msIw |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfGkIAXxDfl00jACwpNYsd2Hsu2aoN1D-sGEy-Wk1wgo2qrtBnqC38gfxXnxOkGVCtCSh7qnK9R7nz3i33-hZCXYCQDP0g9DI_G46EJPSNU7qUyMjI2CWZ1Ow85OBC7x_z9SXSyQbbavTC2rNLF_iam19HatXTd0-xOi6I7ROghlIwx4zAE9Sy-Qq5yHL52dL79sazzEJafpllaFp4VdztnmiKv07SwJKiBquk7a5y5Mjv9jT7_oBat01H_FrnpcCTtNbd6m2zA-A65NnAr5XfJz6HJYb6gk5wixKPblk-2xA74e8uSFphyQQ-hrUN1mzEpHlb6nZkVMyu6V4NHPGBSzegncwZevwSgh1acmnFG-2WzMwJV90eT79RW8pVnQAfnc48zWowpgtpkBOf_3bOlpAu63awP1ap6aTW_IDF0XAqze-S4v3O0teu57zZ4qRJs7mUKYyYXuUoyZoT0E-6bXGRc5nHmQxoYCEM_URm6AUQCYpZGgQREWgr8jGeS3Seb48kYHhIapLHyDZMhGIQaWWgSabKcqdQHbItVhwStvXTqSM3ttzVGuq1eO9XWxtraWPuRRht3yJtln2lD6XGpNGvdQLebVTG8asw4l_aKlr1-c-e1_V60nqZxnNvFm8bEKIRvlgi2w6BDHjQuuLx7Zuel_MjvkNeNTy6vWPLw7eJjT0_KL3pUVBrxP1esQ15dKjiutJSYetbITcpKC0t5uEauqjQTOEjxBndWyI2qKZ4JnnoGWsRxaHjKtBQJ01xx0LFIAh0ziAw6TAih6ZDPK_Q0L6zasWR9dfqmF6a__1H5qqfomr4VVidHP4_5o_808nNyffdosK_39w4-PCY37BW7ShGwJ2RzXlbwFGHuPHlWh7FfomOtPg |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Safety+of+the+Deferral+of+Coronary+Revascularization+on+the+Basis+of+Instantaneous+Wave-Free+Ratio+and+Fractional+Flow+Reserve+Measurements+in+Stable+Coronary+Artery+Disease+and+Acute+Coronary+Syndromes&rft.jtitle=JACC.+Cardiovascular+interventions&rft.au=Escaned%2C+Javier&rft.au=Ryan%2C+Nicola&rft.au=Mej%C3%ADa-Renter%C3%ADa%2C+Hern%C3%A1n&rft.au=Cook%2C+Christopher+M.&rft.date=2018-08-13&rft.issn=1936-8798&rft.volume=11&rft.issue=15&rft.spage=1437&rft_id=info:doi/10.1016%2Fj.jcin.2018.05.029&rft.externalDocID=oai_portal_research_lu_se_publications_6992a4c3_76b3_484e_96b1_93e5a4e52e2a |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1936-8798&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1936-8798&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1936-8798&client=summon |